Table 1 shows the expression of these cytokines in treated tumors as a percent of control tumor cytokine levels. Figure 6 shows differences between control and treatment groups in four key cytokines, IFN-γ, IL-2, IL-4, and IL-12, related to TNBC tumor response. The gene discussed is IFNG; the disease is neoplasm.